Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Translational gene-based medicine

The Molecular Neuromodulation team works closely together with internationally leading AAV experts and clinicians to bring AAV based therapies for Parkinson’s disease to the clinic. The long-term goal of this project is to build a foundation of non-clinical and clinical experience to allow for rapid development of advanced, gene-based therapies in the future.

Molecular Neuromodulation unit
Wallenberg Neuroscience Center
Department of Experimental Medical Science
BMC A10, 221 84 Lund, Sweden
Phone: +46 46 222 68 36
e-Mail: tomas [dot] bjorklund [at] med [dot] lu [dot] se